Barrington Research Raises HealthEquity (NASDAQ:HQY) Price Target to $125.00

HealthEquity (NASDAQ:HQY - Get Free Report) had its target price raised by research analysts at Barrington Research from $112.00 to $125.00 in a research report issued on Thursday,Benzinga reports. The brokerage presently has an "outperform" rating on the stock. Barrington Research's target price would suggest a potential upside of 12.06% from the company's previous close.

Several other brokerages have also commented on HQY. Bank of America raised their price target on shares of HealthEquity from $110.00 to $125.00 and gave the company a "buy" rating in a research note on Wednesday. Raymond James upgraded HealthEquity from an "outperform" rating to a "strong-buy" rating and lowered their target price for the company from $120.00 to $115.00 in a research report on Tuesday, March 25th. Deutsche Bank Aktiengesellschaft raised their target price on HealthEquity from $98.00 to $115.00 and gave the company a "buy" rating in a research report on Thursday. Wells Fargo & Company raised their price target on HealthEquity from $110.00 to $125.00 and gave the company an "overweight" rating in a report on Wednesday, February 26th. Finally, KeyCorp lowered their price target on HealthEquity from $110.00 to $100.00 and set an "overweight" rating on the stock in a report on Wednesday, April 16th. One investment analyst has rated the stock with a hold rating, nine have issued a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat.com, HealthEquity currently has an average rating of "Buy" and a consensus target price of $118.09.

HealthEquity Stock Performance

HQY traded down $1.15 on Thursday, hitting $111.55. 1,893,274 shares of the company's stock were exchanged, compared to its average volume of 828,878. The firm has a market cap of $9.65 billion, a PE ratio of 102.34, a P/E/G ratio of 1.60 and a beta of 0.45. HealthEquity has a twelve month low of $65.01 and a twelve month high of $116.65. The company has a current ratio of 3.20, a quick ratio of 3.20 and a debt-to-equity ratio of 0.51. The stock has a fifty day moving average of $91.48 and a two-hundred day moving average of $97.80.

HealthEquity (NASDAQ:HQY - Get Free Report) last announced its quarterly earnings results on Tuesday, June 3rd. The company reported $0.97 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.81 by $0.16. The business had revenue of $330.80 million for the quarter, compared to the consensus estimate of $322.25 million. HealthEquity had a return on equity of 9.70% and a net margin of 8.41%. During the same quarter last year, the business posted $0.80 EPS. On average, research analysts anticipate that HealthEquity will post 2.32 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, Director Robert W. Selander sold 5,750 shares of HealthEquity stock in a transaction dated Wednesday, April 9th. The stock was sold at an average price of $77.65, for a total value of $446,487.50. Following the transaction, the director now owns 84,969 shares of the company's stock, valued at approximately $6,597,842.85. This trade represents a 6.34% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, EVP Michael Henry Fiore sold 8,881 shares of HealthEquity stock in a transaction that occurred on Friday, April 4th. The stock was sold at an average price of $78.26, for a total transaction of $695,027.06. Following the completion of the transaction, the executive vice president now directly owns 56,655 shares in the company, valued at approximately $4,433,820.30. This trade represents a 13.55% decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.50% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of the business. Arcadia Investment Management Corp MI purchased a new position in HealthEquity during the fourth quarter valued at approximately $26,000. Transce3nd LLC purchased a new position in shares of HealthEquity during the 4th quarter valued at $29,000. WPG Advisers LLC purchased a new position in shares of HealthEquity during the 1st quarter valued at $28,000. Versant Capital Management Inc purchased a new position in shares of HealthEquity during the 1st quarter valued at $28,000. Finally, Smartleaf Asset Management LLC grew its stake in HealthEquity by 34.3% in the fourth quarter. Smartleaf Asset Management LLC now owns 384 shares of the company's stock valued at $37,000 after purchasing an additional 98 shares in the last quarter. Hedge funds and other institutional investors own 99.55% of the company's stock.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.